相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats
Dong Wang et al.
DIGESTIVE AND LIVER DISEASE (2015)
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients
Holly L. Geyer et al.
BLOOD (2014)
Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications
Emmanuel Pourcelot et al.
EXPERIMENTAL HEMATOLOGY (2014)
A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis
Christen L. Andersen et al.
HAEMATOLOGICA (2014)
Elevated Levels of Mast Cells Are Involved in Pruritus Associated with Polycythemia Vera in JAK2V617F Transgenic Mice
Xi Jin et al.
JOURNAL OF IMMUNOLOGY (2014)
Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
Hans Carl Hasselbalch
LEUKEMIA RESEARCH (2013)
Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
Rakhee Vaidya et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
Hans Carl Hasselbalch
BLOOD (2012)
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
Robyn M. Emanuel et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients
Robyn Scherber et al.
BLOOD (2011)
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
Angela G. Fleischman et al.
BLOOD (2011)
Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
Henrik Frederiksen et al.
BLOOD (2011)
Evaluating the Serial Use of the Myelofibrosis Symptom Assessment Form for Measuring Symptomatic Improvement Performance in 87 Myelofibrosis Patients on a JAK1 and JAK2 Inhibitor (INCB018424) Clinical Trial
Ruben A. Mesa et al.
CANCER (2011)
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
Tiziano Barbui et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
Naseema Gangat et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
Ayalew Tefferi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?
Julienne E. Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Francisco Cervantes et al.
BLOOD (2009)
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera
Lisa Pieri et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms
J. Wang et al.
LEUKEMIA (2009)
The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis
Ruben A. Mesa et al.
LEUKEMIA RESEARCH (2009)
Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines
Oliver Bock et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Cytokines and their relationship to the symptoms and outcome of cancer
Bostjan Seruga et al.
NATURE REVIEWS CANCER (2008)
TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells
June Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Historical insights into cytokines
Charles A. Dinarello
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Differential expression of cytokines in painful and painless neuropathies
Nurcan Uceyler et al.
NEUROLOGY (2007)
Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids
Julienne E. Bower et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) - An international internet-based survey of 1179 MPD patients
Ruben A. Mesa et al.
CANCER (2007)
Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers
Nathan L. Sparkman et al.
JOURNAL OF NEUROSCIENCE (2006)
Toll like receptor 4: Link to the anti-inflammatory effects of exercise?
Michael G. Flynn et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2006)
Fatigue in long-term breast carcinoma survivors - A longitudinal investigation
JE Bower et al.
CANCER (2006)
The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases
Frauke Zipp et al.
TRENDS IN NEUROSCIENCES (2006)
The pivotal role of cytokines in muscle wasting during cancer
JM Argilés et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Low-dose endotoxemia and human neuropsychological functions
KS Krabbe et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
CA Meyers et al.
CANCER (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Inflammatory mediators in the elderly
KS Krabbe et al.
EXPERIMENTAL GERONTOLOGY (2004)
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides
EJB Ramos et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2004)
Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings
DL Musselman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
分享论文
